Allogene Therapeutics, Inc. (ALLO) Earnings
NASDAQ·Healthcare·Biotechnology
$1.91
+1.86%
Mkt Cap $458.47M
EPS — Estimate vs Actual
Mkt Cap
$458.47M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.77
NASDAQ·Healthcare·Biotechnology
$1.91
+1.86%
Mkt Cap $458.47M
Mkt Cap
$458.47M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.77